NO338969B1 - Fremgangsmåte for fremstilling av N-substituerte salisylamider - Google Patents

Fremgangsmåte for fremstilling av N-substituerte salisylamider Download PDF

Info

Publication number
NO338969B1
NO338969B1 NO20073548A NO20073548A NO338969B1 NO 338969 B1 NO338969 B1 NO 338969B1 NO 20073548 A NO20073548 A NO 20073548A NO 20073548 A NO20073548 A NO 20073548A NO 338969 B1 NO338969 B1 NO 338969B1
Authority
NO
Norway
Prior art keywords
ethyl
alkyl
formula
substituted
reaction
Prior art date
Application number
NO20073548A
Other languages
English (en)
Norwegian (no)
Other versions
NO20073548L (no
Inventor
Bernhard Riss
Ulrich Meier
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34090175&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO338969(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NO20073548L publication Critical patent/NO20073548L/no
Publication of NO338969B1 publication Critical patent/NO338969B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/01Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/42Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/44Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/58Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/60Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/01Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/24Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/42Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/44Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/58Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/041,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/121,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/141,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/241,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in positions 2 and 4
    • C07D265/26Two oxygen atoms, e.g. isatoic anhydride

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20073548A 2004-12-16 2007-07-09 Fremgangsmåte for fremstilling av N-substituerte salisylamider NO338969B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0427603.6A GB0427603D0 (en) 2004-12-16 2004-12-16 Organic compounds
PCT/EP2005/013454 WO2006063821A1 (en) 2004-12-16 2005-12-14 Manufacture process of n-substituted salicylamides

Publications (2)

Publication Number Publication Date
NO20073548L NO20073548L (no) 2007-09-17
NO338969B1 true NO338969B1 (no) 2016-11-07

Family

ID=34090175

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20073548A NO338969B1 (no) 2004-12-16 2007-07-09 Fremgangsmåte for fremstilling av N-substituerte salisylamider

Country Status (24)

Country Link
US (1) US8461385B2 (enExample)
EP (2) EP1838664B1 (enExample)
JP (1) JP5224816B2 (enExample)
KR (1) KR101287233B1 (enExample)
CN (1) CN101080384B (enExample)
AR (1) AR055007A1 (enExample)
AU (1) AU2005315850B2 (enExample)
BR (1) BRPI0519327A2 (enExample)
CA (1) CA2587213C (enExample)
ES (1) ES2547349T3 (enExample)
GB (1) GB0427603D0 (enExample)
GT (1) GT200500353A (enExample)
IL (1) IL183366A0 (enExample)
MA (1) MA29092B1 (enExample)
MX (1) MX2007007211A (enExample)
NO (1) NO338969B1 (enExample)
PE (1) PE20060740A1 (enExample)
PL (1) PL1838664T3 (enExample)
PT (1) PT1838664E (enExample)
RU (1) RU2404158C2 (enExample)
TN (1) TNSN07229A1 (enExample)
TW (1) TW200635880A (enExample)
WO (1) WO2006063821A1 (enExample)
ZA (1) ZA200703826B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101627011A (zh) 2005-09-19 2010-01-13 爱密斯菲尔科技公司 N-(5-氯水杨酰基)-8-氨基辛酸的二钠盐的晶形
PL2215047T3 (pl) 2007-11-02 2014-05-30 Emisphere Tech Inc Sposób leczenia niedoborów witaminy b12
CN109473182B (zh) * 2018-11-12 2021-10-19 北京北排科技有限公司 一种基于深度信念网络的mbr膜透水率智能检测方法
CA3141383A1 (en) * 2019-05-20 2020-11-26 Lonza Guangzhou Pharmaceutical Ltd. Method for preparation of carsalam
CN115260116B (zh) * 2022-08-19 2024-04-12 株洲壹诺生物技术有限公司 8-(2-羟基苯甲酰胺基)辛酸钠及苯并噁嗪-2,4-二酮和8-溴辛酸乙酯的制法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000059863A1 (en) * 1999-04-05 2000-10-12 Emisphere Technologies, Inc. Disodium salts, monohydrates, and ethanol solvates
US20030216593A1 (en) * 2000-06-02 2003-11-20 Bay William E. Method of preparing salicylamides

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU382610A1 (ru) * 1968-07-08 1973-05-25 Способ получения амидов карбоновых кислот
TR200200619T2 (tr) * 1999-06-25 2003-01-21 The Institutes For Pharmaceutical Discovery, Llc. İkame edilmiş fenoksiasetik asitler.
ES2386263T3 (es) 2000-03-21 2012-08-14 Emisphere Technologies, Inc. Método de preparación de salicilamidas alquiladas mediante un producto intermedio de dicarboxilato
WO2003057650A2 (en) * 2002-01-09 2003-07-17 Emisphere Technologies, Inc. Polymorphs of sodium 4-[(4-chloro-2-hydroxybenzoyl)amino]butanoate
EP1299348B1 (en) * 2000-06-29 2008-04-09 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US7495030B2 (en) * 2000-09-06 2009-02-24 Emisphere Technologies, Inc. (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents
US7049283B2 (en) * 2000-12-06 2006-05-23 Novartis Ag Pharmaceutical compositions for the oral delivery of pharmacologically active agents
JP4417113B2 (ja) * 2002-02-20 2010-02-17 エミスフェアー・テクノロジーズ・インク Glp−1分子の投与方法
US20050054557A1 (en) * 2002-05-09 2005-03-10 Goldberg Michael M. Compositions for delivering parathyroid hormone and calcitonin

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000059863A1 (en) * 1999-04-05 2000-10-12 Emisphere Technologies, Inc. Disodium salts, monohydrates, and ethanol solvates
US20020065255A1 (en) * 1999-04-05 2002-05-30 Emisphere Technologies, Inc. Disodium salts, monohydrates, and ethanol solvates for delivering active agents
US20030216593A1 (en) * 2000-06-02 2003-11-20 Bay William E. Method of preparing salicylamides

Also Published As

Publication number Publication date
PL1838664T3 (pl) 2016-04-29
CN101080384B (zh) 2011-06-15
AR055007A1 (es) 2007-08-01
NO20073548L (no) 2007-09-17
BRPI0519327A2 (pt) 2009-01-13
TNSN07229A1 (en) 2008-11-21
IL183366A0 (en) 2007-09-20
GB0427603D0 (en) 2005-01-19
RU2404158C2 (ru) 2010-11-20
CN101080384A (zh) 2007-11-28
JP5224816B2 (ja) 2013-07-03
JP2008524142A (ja) 2008-07-10
EP2955171A1 (en) 2015-12-16
GT200500353A (es) 2006-07-17
MX2007007211A (es) 2007-08-15
RU2007126972A (ru) 2009-01-27
EP1838664B1 (en) 2015-07-15
TW200635880A (en) 2006-10-16
ES2547349T3 (es) 2015-10-05
ZA200703826B (en) 2008-08-27
US20090253811A1 (en) 2009-10-08
MA29092B1 (fr) 2007-12-03
AU2005315850A1 (en) 2006-06-22
KR20070086276A (ko) 2007-08-27
PE20060740A1 (es) 2006-09-04
CA2587213A1 (en) 2006-06-22
PT1838664E (pt) 2015-10-16
US8461385B2 (en) 2013-06-11
EP1838664A1 (en) 2007-10-03
WO2006063821A1 (en) 2006-06-22
AU2005315850B2 (en) 2009-11-05
KR101287233B1 (ko) 2013-07-17
CA2587213C (en) 2015-05-19

Similar Documents

Publication Publication Date Title
CZ2004150A3 (cs) Způsob přípravy derivátů 7-amino syn 3,5-dihydroxyheptanové kyseliny přes deriváty 6-kyan syn-3,5-dihydroxyheptanové kyseliny
NO338969B1 (no) Fremgangsmåte for fremstilling av N-substituerte salisylamider
NO338831B1 (no) Fremgangsmåte for fremstilling av N-substituerte salisylamider
EP2630118B1 (en) Synthesis of aliskiren
ES2371063T5 (es) Método para producir 2-(alquil)cicloalquenona
AU728589B2 (en) A method for preparing 3-amino substituted crotonates
ES2215654T3 (es) Procedimiento para la obtencion de esteres de acido alcoxicinamico.
CA2298805C (en) Method for preparing 3-cyano-2,4-dihalogen-5-fluor-benzoic acid
US20040199002A1 (en) Process for producing(2-nitrophenyl)acetonitrile derivative and intermediate therefor
US4501916A (en) Process for preparing alkyl esters of C-alkyl-tartronic or C-halogenalkyl-tartronic acids
JPH06166666A (ja) ヒドラゾン誘導体およびその製造方法
US7368592B1 (en) Process for the preparation of alkyl n-alkylanthranilate
JP3537489B2 (ja) N−長鎖アシルアミノ酸及びその塩の製造法、並びに中間体アミドニトリル、及びその製造法
US20010021787A1 (en) Process for preparing cyanoacetamide
JP4239251B2 (ja) シアノ安息香酸アルキルエステルの製造方法
JPS5928551B2 (ja) イソキサゾ−ル誘導体の製造方法
JPH09316021A (ja) α−分枝長鎖脂肪酸の製造法
JPH0570406A (ja) β,β,β−トリフルオロ乳酸エステル化合物及びその製造方法並びにその光学純度の向上方法
KR20000035350A (ko) N-알콕시카보닐-n-시아노에틸 아미노산 알킬에스테르의제조 방법
MXPA00000861A (en) Method for preparing 3-cyano-2,4-dihalogen-5-fluor-benzoic acid

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees